ArticlePloS one2015

Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical Isolates.

Benoit Visseaux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.